Mulmit

Quoin Pharmaceuticals Ltd.Quoin Pharmaceuticals Ltd.

QNRX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2021-12-310-21,462,588-0.01
2020-12-310-2,095,364-0.7
2019-12-310-1,560,401-0.52

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-31Carter Denise P.Chief Operating Officer20,490
2026-08-31Carter Denise P.Chief Operating Officer10,245
2026-08-31Myers MichaelChief Executive Officer20,490
2026-08-31Myers MichaelChief Executive Officer10,245
2026-08-31Lawlor Sally BridgetChief Financial Officer10,244
2026-08-31Lawlor Sally BridgetChief Financial Officer5,122
2026-08-31Culverwell Anthony James6,146
2026-08-31Culverwell Anthony James3,073
2026-08-27LANGER DENNIS34,534
2026-08-27Culverwell Anthony James31,352
2026-02-04Lawlor Sally BridgetChief Financial Officer85,250
2026-02-04Cooper Joseph Patrick8,141

8-K events

FiledItems
2026-09-10Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-28Entry into a material agreement · Unregistered sales of equity securities · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-20Officer or director change · Submission of matters to a vote · Other events
2026-08-14Results of operations · Financial statements and exhibits
2026-06-23Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-04Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-07Results of operations · Financial statements and exhibits
2026-03-26Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…